446 related articles for article (PubMed ID: 18371472)
1. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
[TBL] [Abstract][Full Text] [Related]
2. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
3. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
Banihashemi B; Goodman SG; Yan RT; Welsh RC; Mehta SR; Montalescot G; Kornder JM; Wong GC; Gyenes G; Steg PG; Yan AT;
Am Heart J; 2009 Dec; 158(6):917-24. PubMed ID: 19958857
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent.
Shammas NW; Dippel EJ; Avila A; Gehbauer L; Farland L; Brosius S; Jerin M; Winter M; Stoakes P; Byrd J; Majetic L; Shammas G; Sharis P; Robken J
J Invasive Cardiol; 2007 Feb; 19(2):77-82. PubMed ID: 17268042
[TBL] [Abstract][Full Text] [Related]
5. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
7. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
[TBL] [Abstract][Full Text] [Related]
9. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
[TBL] [Abstract][Full Text] [Related]
10. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
[TBL] [Abstract][Full Text] [Related]
11. Stent thrombosis is associated with an impaired response to antiplatelet therapy.
Wenaweser P; Dörffler-Melly J; Imboden K; Windecker S; Togni M; Meier B; Haeberli A; Hess OM
J Am Coll Cardiol; 2005 Jun; 45(11):1748-52. PubMed ID: 15936599
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
[TBL] [Abstract][Full Text] [Related]
13. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction.
Lev EI; Alviar CL; Arikan ME; Dave BP; Granada JF; DeLao T; Tellez A; Maresh K; Kleiman NS
Am Heart J; 2007 Jan; 153(1):41.e1-6. PubMed ID: 17174635
[TBL] [Abstract][Full Text] [Related]
14. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
[TBL] [Abstract][Full Text] [Related]
15. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
[TBL] [Abstract][Full Text] [Related]
16. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis.
Ergelen M; Uyarel H; Osmonov D; Ayhan E; Akkaya E; Soylu O; Orhan AL; Sayar N; Bozbay M; Turer A; Yildirim E; Yekeler I
Clin Appl Thromb Hemost; 2010 Feb; 16(1):33-41. PubMed ID: 19736213
[TBL] [Abstract][Full Text] [Related]
17. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
[TBL] [Abstract][Full Text] [Related]
18. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
19. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
Kuchulakanti PK; Chu WW; Torguson R; Ohlmann P; Rha SW; Clavijo LC; Kim SW; Bui A; Gevorkian N; Xue Z; Smith K; Fournadjieva J; Suddath WO; Satler LF; Pichard AD; Kent KM; Waksman R
Circulation; 2006 Feb; 113(8):1108-13. PubMed ID: 16490815
[TBL] [Abstract][Full Text] [Related]
20. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents.
Roy P; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Pichard AD; Waksman R
J Interv Cardiol; 2007 Oct; 20(5):307-13. PubMed ID: 17880326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
